Amgen colorectal cancer therapy gets USFDA nod Ruchika Sharma17 Jan 2025 12:29 PM ISTThe Food and Drug Administration has approved Amgen sotorasib (Lumakras) with panitumumab (Vectibix) for adult patients with KRAS G12C-mutated...
Bristol Myers Squibb gets USFDA accelerated approval for Krazati, Cetuximab combo for colorectal cancer Ruchika Sharma22 Jun 2024 11:11 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for...
Merck gets Canadian nod for Keytruda in combo with fluoropyrimidine- and platinum-containing-chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma Ruchika Sharma23 April 2024 3:08 PM ISTKirkland: Merck, known as MSD outside the United States and Canada, has announced that Health Canada has granted approval of KEYTRUDA...
USFDA approves Takeda Fruzaqla for previously treated Metastatic Colorectal Cancer Ruchika Sharma10 Nov 2023 1:51 PM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved FRUZAQLA (fruquintinib), an oral targeted therapy for...
CHMP recommends nod of Merck Keytruda in combo with trastuzumab, chemotherapy to treat HER2-positive advanced GEJ adenocarcinoma expressing PD-L1 Ruchika Sharma24 July 2023 2:30 PM ISTRahway:Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency’s Committee for Medicinal...
Merck announces positive results from phase 3 KEYNOTE-859 trial of Keytruda plus chemotherapy to treat patients with HER2-negative gastric or GEJ adenocarcinoma Ruchika Sharma20 Feb 2023 2:30 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
